The Regulation of Skin Fibrosis in Systemic Sclerosis by Extracellular ATP via P2Y2 Purinergic Receptor
- 1 April 2019
- journal article
- research article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 139 (4) , 890-899
Abstract
No abstract availableKeywords
Funding Information
- JSPS KAKENHI (17K10205)
- Japanese Society for Investigative Dermatology
- Lydia O’Leary Memorial Pias Dermatological Foundation
This publication has 41 references indexed in Scilit:
- ATP released from cardiac fibroblasts via connexin hemichannels activates profibrotic P2Y 2 receptorsThe FASEB Journal, 2012
- Pericyte-Derived MFG-E8 Regulates Pathologic AngiogenesisArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Extracellular ATP acts on P2Y2 purinergic receptors to facilitate HIV-1 infectionJournal of Experimental Medicine, 2011
- Cellular and molecular aspects of vascular dysfunction in systemic sclerosisNature Reviews Rheumatology, 2010
- Selective Oxidation of DNA Topoisomerase 1 Induces Systemic Sclerosis in the MouseThe Journal of Immunology, 2009
- Extracellular ATP Has Stimulatory Effects on the Expression and Release of IL-6 Via Purinergic Receptors in Normal Human Epidermal KeratinocytesJournal of Investigative Dermatology, 2007
- How does endothelial cell injury start? The role of endothelin in systemic sclerosisArthritis Research & Therapy, 2007
- The role of purinergic P2X7 receptors in the inflammation and fibrosis of unilateral ureteral obstruction in miceKidney International, 2006
- Flavonoids — novel lead compounds for the development of P2Y2 receptor antagonistsDrug Development Research, 2003
- Increased endothelin-1 production in fibroblasts derived from patients with systemic sclerosis.Annals of the Rheumatic Diseases, 1994